When Feng Zhang was in his early 30s, he used a set of genes found in bacteria called CRISPR to pioneer a new kind of gene ...

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed ...

Akin Akinc was scouring his email spam box last summer, looking for a missing message, when he stumbled across an unexpected email from a quite recognizable name: Feng Zhang. Zhang, one of the leading ...

Feng Zhang is a core institute member of the Broad Institute of MIT and Harvard, as well as an investigator at the McGovern Institute for Brain Research at MIT, co-director of the K. Lisa Yang and ...

The gene-editing startup Aera has hired biotech vets Akin Akinc as CEO and John Maraganore as chairman. The two execs previously led the biotech giant Alnylam. They now guide Feng Zhang's latest ...

The Anna Head Alumnae Hall at UC Berkeley was packed with more than 200 attendees Wednesday evening as Feng Zhang, professor of biomedical engineering at the Massachusetts Institute of Technology and ...

Aera Therapeutics is launching with $193 million to develop a new nanoparticle technology to deliver genetic medicines to hard-to-reach parts of the body. Months before Feng Zhang met with a trio of ...

Every time Andrew publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...